|
⚲
|
| Keyboard |
| Evanson Jeff
✚
|
|
|---|---|
| CIK # | 0001760511 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001760511] | |
| 4 | [0001760511] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Evanson Jeff | |
| Outlook Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2024-03-20 | Grant | 25,000 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2024-03-07 | Buy | 62,484 | $0.42 | 26,243 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2023-04-17 | Grant | 192,143 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2023-01-20 | Sell | 267,000 | $1.11 | 296,370 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2023-01-19 | Sell | 103,255 | $1.22 | 125,971 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2023-01-18 | Sell | 33,738 | $1.25 | 42,172 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2023-01-17 | Sell | 27,162 | $1.31 | 35,582 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2022-03-31 | Grant | 100,000 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2021-12-21 | Grant | 800,000 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2021-12-03 | Buy | 35,200 | $1.34 | 47,168 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2021-02-23 | Sell | 8,554 | $2.09 | 17,878 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2021-02-12 | Sell | 56,973 | $2.55 | 145,281 |
|
Outlook Therapeutics Inc OTLK
Common Stock
|
2020-03-19 | Grant | 1,207,457 | $0.00 |